US Map / Louisiana
State LA

Clinical Trials in Louisiana

Louisiana is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Louisiana and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 143 actively recruiting studies with Louisiana sites out of 143 registered in total. The busiest research areas in Louisiana are B Acute Lymphoblastic Leukemia, Venous Leg Ulcer, Ulcerative Colitis. Leading sponsors running trials in the state include Tulane University, National Cancer Institute (NCI), Pennington Biomedical Research Center. By stage, Louisiana trials break down as Phase 1 (8), Phase 2 (32), Phase 3 (53), Phase 4 (4).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
143
Recruiting Now
143
← Back to US Map
Top Conditions in Louisiana
B Acute Lymphoblastic Leukemia (3)Venous Leg Ulcer (3)Ulcerative Colitis (3)Obesity (3)Malignant Solid Neoplasm (2)Human Immunodeficiency Virus (2)Solid Tumor (2)Prostate Adenocarcinoma (2)Mitral Valve Insufficiency (2)Chronic Low-back Pain (2)Heart Failure (2)Alzheimer Disease (2)

Frequently Asked Questions — Clinical Trials in Louisiana

How many clinical trials are currently recruiting in Louisiana?
ClinicalMetric currently tracks 143 actively recruiting clinical trials with at least one location in Louisiana. The total number of registered studies—including active but not currently enrolling trials—is 143. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Louisiana?
Louisiana hosts clinical trials across a broad range of medical conditions, including B Acute Lymphoblastic Leukemia, Venous Leg Ulcer, Ulcerative Colitis, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Louisiana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Louisiana?
To join a clinical trial in Louisiana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Louisiana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Louisiana

NCT05059444 N/A
Recruiting
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Condition
Bladder Carcinoma
Enrollment
2,285 pts
Location
United States, France, Germany
Sponsor
Guardant Health, Inc.
View Trial →
NCT06095128 Phase 4
Recruiting
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Condition
Ulcerative Colitis
Enrollment
65 pts
Location
United States, Canada
Sponsor
Takeda
View Trial →
NCT03180268 Phase 3
Recruiting
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade...
Condition
Grade 2 Meningioma
Enrollment
163 pts
Location
United States, Canada, India
Sponsor
NRG Oncology
View Trial →
NCT07530718 N/A
Recruiting
Body Composition Outcomes in MS Patients
Condition
Obesity
Enrollment
20 pts
Location
United States
Sponsor
Pennington Biomedical Research
View Trial →
NCT07211958 Phase 3
Recruiting
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed...
Condition
Acute Myeloid Leukemias
Enrollment
468 pts
Location
United States, Australia, Austria
Sponsor
Syndax Pharmaceuticals
View Trial →
NCT06938685 N/A
Recruiting
Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers
Condition
Diabetic Foot Ulcer
Enrollment
132 pts
Location
United States
Sponsor
NuScience Medical Biologics, L
View Trial →
NCT05806515 Phase 2
Recruiting
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cance...
Condition
Prostate Adenocarcinoma
Enrollment
44 pts
Location
United States
Sponsor
SWOG Cancer Research Network
View Trial →
NCT07135531 N/A
Recruiting
Continuous Glucose Monitoring (CGM) in an Underserved Population
Condition
Diabetes
Enrollment
50 pts
Location
United States
Sponsor
Tulane University
View Trial →
NCT06643741 N/A
Recruiting
Non-Invasive Preeclampsia Screening and Biobank
Condition
Preeclampsia (PE)
Enrollment
6,550 pts
Location
United States
Sponsor
Sequenom, Inc.
View Trial →
NCT04871542 N/A
Recruiting
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Condition
Malignant Solid Neoplasm
Enrollment
2,062 pts
Location
United States, Chile, Guam
Sponsor
SWOG Cancer Research Network
View Trial →
NCT07759154 Phase 3
Recruiting
A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hy...
Condition
Attention-deficit/Hyperactivity Disorder
Enrollment
80 pts
Location
United States
Sponsor
Otsuka Pharmaceutical Developm
View Trial →
NCT07626411 Phase 3
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibril...
Condition
Atrial Fibrillation (AF)
Enrollment
15,364 pts
Location
United States
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT06124157 Phase 2
Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatme...
Condition
B Acute Lymphoblastic Leukemia
Enrollment
222 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05945329 N/A
Recruiting
Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Brea...
Condition
Capsular Contracture Associated With Breast Implant
Enrollment
250 pts
Location
United States
Sponsor
C. R. Bard
View Trial →
NCT06989112 Phase 3
Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegos...
Condition
Endometrial Cancer
Enrollment
600 pts
Location
United States, Australia, Austria
Sponsor
AstraZeneca
View Trial →
NCT05495334 N/A
Recruiting
Innovations in Genicular Outcomes Registry
Condition
Knee Osteoarthritis
Enrollment
10,000 pts
Location
United States
Sponsor
Pacira Pharmaceuticals, Inc
View Trial →
NCT07062406 N/A
Recruiting
Enhancing Diabetes Care by Treating Insomnia
Condition
Diabetes Type 2
Enrollment
30 pts
Location
United States
Sponsor
Tulane University
View Trial →
NCT06133322 N/A
Recruiting
Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSE...
Condition
Hypertension
Enrollment
1,176 pts
Location
United States
Sponsor
Tulane University
View Trial →
Page 6 of 6 — 143 trials total
← Prev
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology